AR002992A1 - Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin. - Google Patents

Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.

Info

Publication number
AR002992A1
AR002992A1 ARP960102396A AR10239696A AR002992A1 AR 002992 A1 AR002992 A1 AR 002992A1 AR P960102396 A ARP960102396 A AR P960102396A AR 10239696 A AR10239696 A AR 10239696A AR 002992 A1 AR002992 A1 AR 002992A1
Authority
AR
Argentina
Prior art keywords
treatment
erectile
decrease
application
pharmaceutical composition
Prior art date
Application number
ARP960102396A
Other languages
English (en)
Inventor
Ho-Leung Fung
John A Bauer
Original Assignee
Baker Norton Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharmaceutical Inc filed Critical Baker Norton Pharmaceutical Inc
Publication of AR002992A1 publication Critical patent/AR002992A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones farmacéuticas en forma local o parenteral que contienen nitritos orgánicos que son efectivas en el tratamiento de impotencia masculinay disfunción eréctil mediante administración local o intracavernosa al pene. También se describen métodos de tratamiento que utilizan composicionesconteniendo nitrito, así como también ciertos compuestos novedosos de nitrito orgánico.
ARP960102396A 1995-05-02 1996-04-30 Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin. AR002992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/432,892 US5646181A (en) 1992-07-02 1995-05-02 Method and compositions for treating impotence

Publications (1)

Publication Number Publication Date
AR002992A1 true AR002992A1 (es) 1998-05-27

Family

ID=23717999

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102396A AR002992A1 (es) 1995-05-02 1996-04-30 Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.

Country Status (9)

Country Link
US (1) US5646181A (es)
EP (1) EP0783283A4 (es)
AR (1) AR002992A1 (es)
AU (1) AU702338B2 (es)
CA (1) CA2208666A1 (es)
IL (1) IL117957A (es)
TW (1) TW434013B (es)
WO (1) WO1996034583A1 (es)
ZA (1) ZA963185B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
CA2295595A1 (en) 1997-07-09 1999-01-21 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US20020055702A1 (en) * 1998-02-10 2002-05-09 Anthony Atala Ultrasound-mediated drug delivery
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US6482426B1 (en) * 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
WO2002007757A2 (en) * 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
EA005649B1 (ru) 2000-08-11 2005-04-28 Дэвид Р. Уитлок Композиции, содержащие аммиакокисляющие бактерии, увеличивающие продуцирование окиси азота и предшественников окиси азота, и способы их использования
BR0306868A (pt) * 2002-01-11 2005-04-12 David R Whitlock Composições incluindo bactérias oxidando amonìaco e métodos para usar as mesmas
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
US20060013769A1 (en) * 2004-07-16 2006-01-19 Stephen Carter Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein
SE0402221D0 (sv) * 2004-09-14 2004-09-14 Aerocrine Ab Treatment of insufficient perfusion
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
AU2007225489A1 (en) * 2006-03-14 2007-09-20 Lars E Gustafsson New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use
US7625852B2 (en) * 2006-06-07 2009-12-01 Henry Hadry Nail polish remover
US8852082B2 (en) * 2008-10-10 2014-10-07 Peter Forsell Stimulation of penis erection
US9216222B2 (en) * 2013-10-15 2015-12-22 Southwest Research Institute Isoamyl nitrite formulations
WO2015160911A2 (en) 2014-04-15 2015-10-22 Aobiome Llc Ammonia-oxidizing nitrosomonas eutropha strain d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
US10842664B2 (en) * 2015-10-29 2020-11-24 Arizona Board Of Regents On Behalf Of Arizona State University Skin-like condoms having active ingredients to enhance a male erection and a female arousal
GB2579240B (en) * 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New medical uses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3213147A (en) * 1963-01-16 1965-10-19 Purdue Research Foundation Process for the production of alpha, omega-dinitroalkanes
DE2144420C3 (de) * 1971-09-04 1978-11-23 Basf Ag, 6700 Ludwigshafen Salpetrigsäureester von Glykolen und Glykolderivaten, deren Herstellung und Verwendung
US3760012A (en) * 1971-12-10 1973-09-18 Texaco Inc Preparation of 1,3-dinitroalkanes
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
NL8802276A (nl) * 1988-09-15 1990-04-02 Cedona Pharm Bv Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Also Published As

Publication number Publication date
AU5387796A (en) 1996-11-21
TW434013B (en) 2001-05-16
ZA963185B (en) 1996-10-30
WO1996034583A1 (en) 1996-11-07
EP0783283A4 (en) 2000-05-10
IL117957A0 (en) 1996-08-04
AU702338B2 (en) 1999-02-18
IL117957A (en) 2000-01-31
US5646181A (en) 1997-07-08
CA2208666A1 (en) 1996-11-07
EP0783283A1 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
CO5050298A1 (es) Metodo y composicion para tratar impotencia
PA8565901A1 (es) Derivados de dihidrobenzodiazepin-2-ona iii
UY28150A1 (es) Agentes terapeuticos
ES2183945T3 (es) Composiciones para mejorar el aporte de un agente por electrotransporte.
ECSP055840A (es) Derivados de 4 -tetrazolil-4fenilpiperidina para el tratamiento del dolor
PE20040165A1 (es) Uso de analogos del benzimidazol en el tratamiento de la proliferacion celular
GT200100016A (es) Pirido[2,3,-d]pirimidin-2,7-diaminas inhibidoras de cinasas.
MY138535A (en) 2-phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors
AR029288A1 (es) Derivados de 1-sulfonil-pirrolidina
AR003455A1 (es) Derivados tetraciclicos, su uso en la preparacion de un medicamento, un metodo de tratamiento, una composicion farmaceutica y procesos para lapreparacion de una composicion farmaceutica y para preparar los compuestos.
AR016662A1 (es) Composicion y metodo para inhibir el crecimiento de microorganismos, la cual incluye hipobromito de sodio estabilizado e isotiazolonas.
GT199900146A (es) Derivados de 4,4-biarilpiperidina.
ATE245650T1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
BR9911408A (pt) Formas de dosagem contendo apomorfina paramelhora de disfunção erétil masculina
MY125490A (en) Method of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
BG104528A (en) Method and means for the treatment of impotence
SE9702681D0 (sv) Method and composition for treatment of impotence
DE69739970D1 (de) Methode zur behandlung sexueller fehlfunktionen
ES2038479T3 (es) Fluido lubricante para la laminacion en frio de acero.
UY26678A1 (es) El uso de composiciones a base de antibióticos de azalidos para tratar o prevenir una infección bacteriana o protozoaria en mamíferos
ATE557007T1 (de) Arylpyrimidine geeignet zur behandlung von sexualhormonbedingten zuständen wie endometriose, prostatakrebs und dergleichen
ATE264861T1 (de) 5-heterozyklyl-pyrazolo(4,3-d)pyrimidin-7-one für die behandlung von männlichen erectilen dysfunktionen
ES2099293T3 (es) Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal